Chandler SP - Search Results

1

Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years: A Randomized Clinical Trial.

Zadnik K, Schulman E, Flitcroft I, Fogt JS, Blumenfeld LC, Fong TM, Lang E, Hemmati HD, Chandler SP; CHAMP Trial Group Investigators. Zadnik K, et al. Among authors: chandler sp. JAMA Ophthalmol. 2023 Oct 1;141(10):990-999. doi: 10.1001/jamaophthalmol.2023.2097. JAMA Ophthalmol. 2023. PMID: 37261839 Free PMC article.

2

Safety and efficacy of bromfenac ophthalmic solution (Bromday) dosed once daily for postoperative ocular inflammation and pain.

Henderson BA, Gayton JL, Chandler SP, Gow JA, Klier SM, McNamara TR; Bromfenac Ophthalmic Solution (Bromday) Once Daily Study Group. Henderson BA, et al. Among authors: chandler sp. Ophthalmology. 2011 Nov;118(11):2120-7. doi: 10.1016/j.ophtha.2011.04.035. Epub 2011 Jul 16. Ophthalmology. 2011. PMID: 21762992 Clinical Trial.

3

Once daily dosing of bromfenac ophthalmic solution 0.09% for postoperative ocular inflammation and pain.

Silverstein SM, Cable MG, Sadri E, Peace JH, Fong R, Chandler SP, Gow JA, Klier SM, McNamara TR; Bromfenac Ophthalmic Solution Once Daily (Bromday) Study Group. Silverstein SM, et al. Among authors: chandler sp. Curr Med Res Opin. 2011 Sep;27(9):1693-703. doi: 10.1185/03007995.2011.597663. Epub 2011 Jul 14. Curr Med Res Opin. 2011. PMID: 21751945 Clinical Trial.

4

Fragile X (CGG)n repeats induce a transcriptional repression in cis upon a linked promoter: evidence for a chromatin mediated effect.

Chandler SP, Kansagra P, Hirst MC. Chandler SP, et al. BMC Mol Biol. 2003 Mar 21;4:3. doi: 10.1186/1471-2199-4-3. Epub 2003 Mar 21. BMC Mol Biol. 2003. PMID: 12659659 Free PMC article.

5

Methods for the analysis of protein-chromatin interactions.

Brickwood SJ, Myers FA, Chandler SP. Brickwood SJ, et al. Among authors: chandler sp. Mol Biotechnol. 2002 Jan;20(1):1-15. doi: 10.1385/MB:20:1:001. Mol Biotechnol. 2002. PMID: 11876294 Review.

6

The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA.

Chandler SP, Guschin D, Landsberger N, Wolffe AP. Chandler SP, et al. Biochemistry. 1999 Jun 1;38(22):7008-18. doi: 10.1021/bi990224y. Biochemistry. 1999. PMID: 10353812

7

Architectural specificity in chromatin structure at the TATA box in vivo: nucleosome displacement upon beta-phaseolin gene activation.

Li G, Chandler SP, Wolffe AP, Hall TC. Li G, et al. Among authors: chandler sp. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4772-7. doi: 10.1073/pnas.95.8.4772. Proc Natl Acad Sci U S A. 1998. PMID: 9539814 Free PMC article.

8

Blood pressure reactivity in urban youth during angry and normal talking.

Liehr P, Meininger JC, Mueller W, Chandler SP, Chan W. Liehr P, et al. Among authors: chandler sp. J Cardiovasc Nurs. 1997 Jul;11(4):85-94. doi: 10.1097/00005082-199707000-00009. J Cardiovasc Nurs. 1997. PMID: 9200022

9

Specificity of antiparallel DNA triple helix formation.

Chandler SP, Fox KR. Chandler SP, et al. Biochemistry. 1996 Nov 26;35(47):15038-48. doi: 10.1021/bi9609679. Biochemistry. 1996. PMID: 8942670

10

Footprinting studies on ligands which stabilize DNA triplexes: effects on stringency within a parallel triple helix.

Chandler SP, Strekowski L, Wilson WD, Fox KR. Chandler SP, et al. Biochemistry. 1995 May 30;34(21):7234-42. doi: 10.1021/bi00021a039. Biochemistry. 1995. PMID: 7766634

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page